High concentration suspension formulation for cold and flu soft gel capsule medications
US11911517B2 · kind B2 · utility
0Cited by
20References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2019 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | May 13, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides for suspension-based pharmaceutical formulations for cold and flu medications, specifically suspension formulations and soft gel capsule dosage forms having reduced size. The present disclosure also provides methods of preparing the suspensions and soft gel capsule dosage forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.